Loading clinical trials...
Loading clinical trials...
This study evaluated the efficacy and safety of enhanced extracorporeal counterpulsation for cardiac rehabilitation in patients after DCB for acute myocardial infarction.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences
NCT06710184 · NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI)
NCT06939738 · Acute Myocardial Infarction (AMI)
NCT06744322 · Acute Myocardial Infarction (AMI)
NCT07293923 · Cardiogenic Shock, Heart Failure, and more
NCT06118281 · Cardiovascular Risk, Acute Myocardial Infarction (AMI)
P-ECP/TI EECP device
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions